BD BBL™ Sabouraud Dextrose Agar (Deep Fill) 221180Recalls & reported problems
Becton, Dickinson And Company · BD BBL™ Sabouraud Dextrose Agar · Class 1
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 3
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 10382902211805), received between Mar 15, 2021 and Jun 9, 2022 — classified as 3 malfunctions.
The most frequently reported specific device problem is “Contamination” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Contamination1
- Device Markings/Labelling Problem1
- Incorrect, Inadequate or Imprecise Result or Readings1
Patient problems
- No Clinical Signs, Symptoms or Conditions3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
MalfunctionJun 9, 2022Contamination; Contamination
IT WAS REPORTED THAT ONE BD BBL¿ SABOURAUD DEXTROSE AGAR (DEEP FILL) PLATE WAS CONTAMINATED PRIOR TO USE. NO PATIENTS WERE INVOLVED. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: A SINGLE PLATE IN QC MICROBIOLOGY LAB WAS DISCOVERED TO HAVE MOLD GROWTH INSIDE A NEWLY OPENED STERILE SLEEVE. QA ANALYST OBSERVED MOLD GROWTH ON TOP OF THE AGAR OF ONE SDA (SABOURAUD DEXTROSE AGAR). IT WAS IDENTIFIED WHILE PERFORMING BIOBURDEN TESTING.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 14648117 ↗MalfunctionOct 19, 2021Device Markings/Labelling Problem; Device Markings/Labelling Problem
IT WAS REPORTED THAT THE BD BBL¿ SABOURAUD DEXTROSE AGAR (DEEP FILL) EXPERIENCED MISSING LABEL INFORMATION. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: MISSING A LABEL.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 12657196 ↗MalfunctionMar 15, 2021Incorrect, Inadequate or Imprecise Result or Readings; Incorrect, Inadequate or Imprecise Result or Readings
IT WAS REPORTED THAT PRIOR TO USE WIT BD BBL¿ SABOURAUD DEXTROSE AGAR (DEEP FILL) MICROORGANISM GROWTH WAS DISCOVERED.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 11482588 ↗
Other CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL devices
- REMEL R02041Remel, Inc. · Culture Media, Selective And Differential3 recalls0 reports
- BD BBL™ MacConkey II Agar 221270Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL1 recall64 reports
- CHROMID® Candida AgarBiomerieux SA · CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL1 recall28 reports
- CHROMID® C. difficileBiomerieux SA · CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL1 recall3 reports
- REMEL R02049Remel, Inc. · Culture Media, Selective And Differential1 recall0 reports
- Strep Selective II Agar R01859Remel, Inc. · Culture Media, Selective And Differential1 recall0 reports
- BD BBL™ CHROMagar™ Candida 254093Becton, Dickinson And Company · CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL29 reports
- CHROMID® S. aureus Elite agarBiomerieux SA · CULTURE MEDIA, SELECTIVE AND DIFFERENTIAL9 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page